ViziLite ® Plus oral lesion identification and marking system
The newest tool in the fight against oral disease is the ViziLite ® Plus oral lesion identification and marking system. ViziLite ® Plus, from Zila Pharmaceuticals, combines the oral screening technology of ViziLite, an advanced chemiluminescent light technology to help detect oral abnormalities, with TBlue630T. TBlue630 is the only patented pharmaceutical-grade form of toluidine blue that has been cleared by the FDA for use in marking lesions identified during a ViziLite examination. ViziLite Plus makes oral screening more comprehensive than ever before and is indicated for use in individuals at increased risk of oral cancer. If ViziLite reveals an abnormality, TBlue630 can be used to mark suspicious lesions for further evaluation. |
Call For An Appointment Now!
|
|
![]() |
© 2012, Internet Dental Alliance, Inc. All Rights Reserved - Privacy Policy - Terms of Use
Beverly Hills Sedation Dentistry | Sedation Dentistry Beverly Hills | Beverly Hills Sedation Dentist | West Hollywood Sedation Dentistry | Bel Air Sedation Dentist | Santa Monica Sedation Dentistry | Los Angeles Sedation Dentist | sitemap
Naomeh Mashhood DDS PC PA, 8500 Wilshire Blvd Suite 602, Beverly Hills, California 90211 - (310) 289-1101
Dr. Naomeh Mashhood